MYGN

NASDAQStock

Myriad Genetics, Inc.

$4.67-0.18 (-3.71%)

52-Week Range

$3.84

$10.12

Key Stats

Market Cap

436.7M

P/E Ratio

—

Dividend Yield

—

Beta

1.93

Volume

1.4M

Avg Volume

2.1M

Performance

+7.06%

-30.62%

-33.65%

YTD

-21.01%

-51.84%

-79.57%

-84.34%

Price Chart

ETF Exposure

MYGN is held by 141 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	20	$100	$8.9M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	25	$124	$8.2M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	134	$675	$29.8M	0.32%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	120,085	$608K	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	22,876	$116K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	53,778	$268K	$37.50B	0.03%
SPGM	State Street SPDR Portfolio MSCI Global Stock Market ETF	0.00%	2,724	$13K	$1.43B	0.09%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.00%	16,159	$78K	$11.88B	0.03%
USFM.L	UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.00%	356	$2K	$134.4M	0.25%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	1,082	$5K	$609.7M	0.12%
VTHR	Vanguard Russell 3000 ETF	0.00%	7,148	$40K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	2,776,877	$15.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	14,605	$111K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,259	$10K	$1.29B	0.17%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	5,714,894	$27K	$3.91B	0.07%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	2,107	$11K	$2.84B	0.19%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	207	$1K	$725.0M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	635	$3K	$1.67B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	1,835	$9K	$3.23B	0.20%
AVSU	Avantis Responsible U.S. Equity ETF	0.00%	3	$15	$412.5M	0.15%
AVUS	Avantis U.S. Equity ETF	0.00%	2,500	$15K	$10.96B	0.15%
DFAT	Dimensional - US Targeted Value ETF	0.00%	12,035	$58K	$12.55B	0.28%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	8	$38	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	25	$128	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	43	$218	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	50	$251	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	59	$297	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	49	$247	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	32	$163	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	24	$123	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	11	$54	$9.3M	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	1,940	$11K	$6.8M	0.60%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	11	$54	$163.7M	0.12%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	1,940	$11K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	1,940	$11K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	136	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	4,877	$37K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	1,940	$11K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	1,940	$11K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	23	$179	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	120,085	$48K	$14.63B	0.20%

PreviousPage 3 of 3

About MYGN ETF Exposure

Myriad Genetics, Inc. (MYGN) is held by 141 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 436.7M, MYGN is a widely held institutional stock. The stock currently trades at $4.67. Investors can gain exposure to MYGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MYGN, sorted by portfolio weight.